TGFB1 and hepatocellular carcinoma: Interestingly, tumor cells bearing early TGF-β signature were selectively enriched for growth inhibitory responsiveness, whereas HCC subsets with the late TGF-β signature preferentially displayed an upregulation of positive cell cycle regulators (e.g., cyclins and CDKs), and genes pertaining to the invasive phenotype and EMT.